New drug discovery research collaboration between Korea & UK

South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...

April 19, 2023 | Wednesday | News
Eisai invests ¥ 8.5 B to revamp Tsukuba Research Laboratories in Japan

Japanese pharmaceutical firm Eisai Co. has announced the completion of a major renovation of its Tsukuba Research Labora...

April 8, 2023 | Saturday | News
Japanese firm Takeda Pharma inks $415 M deal for celiac disease research

French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...

April 3, 2023 | Monday | News
Japan's NEC establishes European subsidiaries for strengthening global AI drug development biz

Japan-based NEC Corporation announced in 2019 that it would expand the application of its cutting-edge artificial inte...

March 31, 2023 | Friday | News
GHIT fund in Japan invests $2.9 M for treatment of neglected tropical diseases

The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 400 mi...

March 30, 2023 | Thursday | News
Collaboration in Korea to develop innovative therapeutic antibodies

Genuv Inc., a clinical-stage biotechnology startup focused on drug discovery, and South Korea headquartred Celltrion, a ...

March 17, 2023 | Friday | News
Australia achieves clinical trial success for psoriasis drug

A company launched from Australia-based University of Queensland’s Institute for Molecular Bioscience (I...

March 15, 2023 | Wednesday | News
Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome

A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...

March 13, 2023 | Monday | News
Australia to launch revolutionary new cholesterol drug in next two years

Hundreds of thousands of Australians with life-threatening high cholesterol are set to benefit from a revolutionary new ...

March 7, 2023 | Tuesday | News
Japanese firms Teijin and Axcelead establish joint venture for drug discovery research

Japan-based pharmaceutical companies Teijin Limited and Axcelead, Inc. have jointly announced their basic agreemen...

February 23, 2023 | Thursday | News
Australia's Inventia partners with Merck to develop 3D models for neuro disease drug discovery

Australia-based startup Inventia Life Science has partnered with American pharmaceutical firm Merck using Inventia'...

February 17, 2023 | Friday | News
Advances in Oncology Drug Development

Oncology is the growth engine of the pharma industry. The oncology drug market totaled $193 billion in sales in 2021 and...

February 7, 2023 | Tuesday | Opinion
"We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"

Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...

January 16, 2023 | Monday | Opinion
Otsuka and Schrödinger announce single-target, drug discovery partnership in neurology

Japanese firm Otsuka Pharmaceutical has announced that the company and its UK-based subsidiary Astex Pharmaceuticals are...

January 13, 2023 | Friday | News
BioNTech expands by leveraging AI-powered Drug discovery, design and development

BioNTech SE and InstaDeep Ltd. have entered partnership under which BioNTech will acquire InstaDeep to build AI-driven d...

January 11, 2023 | Wednesday | News
Japanese startup Veritas In Silico inks new partnership for mRNA-targeted small molecule drug discovery

Japan-based startup Veritas In Silico has entered into a joint drug discovery research agreement with RaQualia Pharma to...

December 30, 2022 | Friday | News
China-based startup XtalPi joins hands with Singapore's national platform for cancer drug discovery

China-based XtalPi, a pioneering pharmaceutical technology startup powered by artificial intelligence (AI) and automatio...

December 21, 2022 | Wednesday | News
Sosei Heptares & Eli Lilly ink $730 M deal for treatment of diabetes and metabolic diseases

Japan-based Sosei Group Corporation has entered a drug discovery collaboration with Eli Lilly and Company, to discover, ...

December 20, 2022 | Tuesday | News